Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report

Simple item page
dc.contributor.authorFuertes Recuero, Manuel
dc.contributor.authorMartínez De Merlo, Elena
dc.contributor.authorLizasoain Sanz, Guillermo
dc.contributor.authorArroba Alonso, Amanda
dc.contributor.authorSánchez López, Alejandro
dc.contributor.authorSuárez Redondo, María
dc.contributor.authorOrtiz Díez, Gustavo
dc.contributor.authorVázquez Fernández, Esther
dc.date.accessioned2024-04-02T11:57:39Z
dc.date.available2024-04-02T11:57:39Z
dc.date.issued2024-03-08
dc.descriptionAuthor contributions: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by MFR, GLS, AAA, ASL, EMM, MSR, EVF and GOD. The first draft of the manuscript was written by MFR and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
dc.description.abstractExocrine pancreatic carcinomas are rarely reported in dogs. A ductal pancreatic adenocarcinoma in a 10-year-old intact beagle is described in this report. The diagnosis was made based on clinical signs, imaging (abdominal ultrasound and CT scan) and histopathology. Treatment consisted of partial right lobe pancreatectomy followed by adjuvant therapy with toceranib phosphate (Palladia®) and firocoxib (Previcox®) for six months. The treatment was well tolerated, and the survival time was 445 days. To our knowledge, this is the longest survival reported in the literature for a dog diagnosed with exocrine pancreatic adenocarcinoma. The results described here may contribute to provide a better understanding about this neoplasia and potential treatment options.
dc.description.departmentDepto. de Sanidad Animal
dc.description.facultyCentro de Vigilancia Sanitaria Veterinaria (VISAVET)
dc.description.facultyFac. de Veterinaria
dc.description.refereedTRUE
dc.description.sponsorshipConsejo Superior de Investigaciones Científicas
dc.description.statuspub
dc.identifier.citationFuertes-Recuero M*, Vazquez-Fernandez E, Lizasoain-Sanz G, Arroba-Alonso A, Sanchez-Lopez A, Martinez-de Merlo E, Suarez-Redondo M and Ortiz-Diez G. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report. Veterinary Research Communications, 1-7. 2024. (A). ISSN: 0165-7380. Impact factor 2022: 2.200. Category: Veterinary Sciences, Quartile: 2, Position: 38 of 143. DOI: 10.1007/s11259-024-10349-5
dc.identifier.doi10.1007/s11259-024-10349-5
dc.identifier.issn0165-7380
dc.identifier.issn1573-7446
dc.identifier.officialurl10.1007/s11259-024-10349-5
dc.identifier.urihttps://hdl.handle.net/20.500.14352/102514
dc.journal.titleVeterinary Research Communications
dc.language.isoeng
dc.publisherSpringer
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu636.09
dc.subject.keywordPancreatic adenocarcinoma
dc.subject.keywordDog
dc.subject.keywordSurgical resection and toceranib phosphate
dc.subject.ucmVeterinaria
dc.subject.unesco3109 Ciencias Veterinarias
dc.titlePancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublicationad803679-c1eb-4c96-a179-a83836edcb20
relation.isAuthorOfPublication386865c1-d413-4348-93d3-070b24f2ffc5
relation.isAuthorOfPublication62d47891-f33b-4009-a53c-996e05843304
relation.isAuthorOfPublication.latestForDiscoveryad803679-c1eb-4c96-a179-a83836edcb20
Download
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1816.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format
Description:
Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report
downoload Download
Collections
Artículos